12 Senate Democrats Unveil Plan to Cut Costs, Expand Coverage
Marissa Plescia / medcitynews - In a recent letter, Senate Democrats proposed lowering healthcare costs, expanding coverage and cracking down on insurance company practices.The post 12 Senate Democrats Unveil Plan to Cut Costs, Expand Coverage appeared first on MedCity News.
AI Summary: A group of Senate Democrats released a package targeting insurance costs and access, proposing steps to lower premiums, expand coverage pathways and increase oversight of insurers. The agenda signals a coordinated legislative push to tackle affordability and industry practices, setting the stage for heated negotiations with stakeholders who enjoy the current status quo.
- Medicaid enrollment threatened by work requirements and redeterminations (5)
- Other health policy, market and access stories (9)
- PBMs, insulin pricing face bipartisan and regulatory pressure (6)
- Senate Democrats push reforms to curb insurer power (4)
- All Other Stories
Medicaid enrollment threatened by work requirements and redeterminations
Other health policy, market and access stories
PBMs, insulin pricing face bipartisan and regulatory pressure
Senate Democrats push reforms to curb insurer power
All Other Stories
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Ayisha Sharma / endpoints - Novartis has budgeted $2 billion upfront to buy a more selective PI3Kα inhibitor for breast cancer. The Swiss pharma already has Piqray with a similar target, but drugmakers are now entering the next-generation era as ...
AI Summary: Novartis agreed to pay $2 billion upfront to acquire Synnovation’s mutant‑selective PI3Kα inhibitor, a bet to revive and strengthen PI3K‑targeting combination strategies in breast cancer. The deal swaps in external innovation for internal development speed, shoring up the company’s oncology pipeline while quietly admitting buying is sometimes faster than building.